Captor Therapeutics SA
60Q
Company Profile
Business description
Captor Therapeutics SA is a biopharmaceutical company. It is focused on development of protein degradation drugs for cancer and autoimmune diseases, which have limited or no known treatment options.
Contact
ul. Dunska 11
Wroclaw54-427
POLT: +48 537869089
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
82
Stocks News & Analysis
stocks
Undervalued REIT receives offer from PE firm
Our analysts’ view on the value of the unsolicited offer.
stocks
Apple: With launch of foldable iPhone duo things look twice as nice
We’ve raised our fair value estimate of Apple stock.
stocks
What did Morningstar subscribers buy and sell during August?
Earnings season fuels trading activity.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,886.70 | 19.70 | -0.22% |
| CAC 40 | 8,116.76 | 0.00 | 0.00% |
| DAX 40 | 25,361.15 | 215.30 | -0.84% |
| Dow JONES (US) | 52,064.10 | 316.56 | -0.60% |
| FTSE 100 | 10,608.92 | 61.14 | -0.57% |
| HKSE | 24,742.51 | 211.96 | -0.85% |
| NASDAQ | 26,081.72 | 171.62 | -0.65% |
| Nikkei 225 | 63,509.22 | 1,761.73 | -2.70% |
| NZX 50 Index | 13,592.54 | 118.47 | -0.86% |
| S&P 500 | 7,591.70 | 44.66 | -0.58% |
| S&P/ASX 200 | 8,708.50 | 9.40 | -0.11% |
| SSE Composite Index | 3,862.73 | 71.67 | -1.82% |